Related Experiment Videos
Diagnostic assays for leprosy based on T-cell epitopes.
H M Dockrell1, S Brahmbhatt, B D Robertson
1Immunology Unit, Department of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
Leprosy Review
|February 24, 2001
Summary
Researchers developed synthetic peptides to identify specific leprosy antigens. This approach aims to create a diagnostic skin test for Mycobacterium leprae, offering potential for community exposure monitoring.
Area of Science:
- Immunology
- Microbiology
- Tropical Diseases
Background:
- Limited specific antigens for Mycobacterium leprae (M. leprae) hinder leprosy diagnosis.
- Existing antigens often share homologues with other mycobacteria, complicating specificity.
- The UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases initiated a project to find M. leprae-specific diagnostic tools.
Purpose of the Study:
- To investigate synthetic peptides encoding T-cell epitopes as potential diagnostic reagents for leprosy.
- To identify M. leprae-specific peptides with unique sequences or significant dissimilarity to other mycobacteria.
- To develop a specific skin-test reagent for leprosy detection.
Main Methods:
- Synthesized 15-amino acid synthetic peptides from 33 M. leprae genes/open reading frames.
- Tested peptides on tuberculoid leprosy patients from endemic countries (Brazil, Ethiopia, Nepal, Pakistan) and UK blood donors (controls).
- Identified peptides showing specific responses in patients versus controls, and cross-reactive peptides present in both groups.
Main Results:
- A sequence difference of five or more amino acids from M. tuberculosis did not guarantee M. leprae specificity.
- Some peptides may have homologues in environmental mycobacteria.
- Identified peptides with >90% specificity and 19-47% sensitivity, currently undergoing further testing.
Conclusions:
- Synthetic peptides show promise as T-cell reagents for leprosy diagnosis.
- Further specificity testing is required for identified peptides.
- These peptides could be formulated as skin-test reagents or in vitro antigens to monitor M. leprae exposure.